Department of Epidemiology, Columbia University Mailman School of Public Health, 722 West 168th St Room 509, New York, NY, 10032, USA.
School of Government & Public Policy, University of Arizona, Tucson, USA.
J Gen Intern Med. 2023 May;38(6):1493-1500. doi: 10.1007/s11606-022-07948-w. Epub 2022 Nov 30.
Simultaneous cannabis/alcohol use, using both substances within a short time interval so that their effects overlap, has a greater risk of potential negative consequences than single-substance use and is more common in younger age. Relationships between recreational cannabis laws (RCLs) and changes in simultaneous cannabis/alcohol use prevalence remain untested.
To examine trends in simultaneous cannabis/alcohol use from 2008 to 2019, and investigate associations between implementation of RCLs (i.e., presence of active legal dispensaries or legal home cultivation) and simultaneous cannabis/alcohol use in the United States (U.S.).
Repeated cross-sectional samples from the 2008-2019 U.S. National Survey on Drug Use and Health (NSDUH).
Respondents (51% female) aged 12 and older.
Changes in simultaneous cannabis/alcohol use before and after RCL implementation (controlling for medical cannabis law implementation) were compared in different age groups (12-20, 21-30, 31-40, 41-50, 51+), using adjusted multi-level logistic regression with state random intercepts and an RCL/age group interaction.
Self-reported simultaneous cannabis/alcohol use.
From 2008 to 2019, the overall prevalence of simultaneous cannabis/alcohol use declined among those aged 12-20 but increased in adults aged 21+. Model-based simultaneous cannabis/alcohol use prevalence increased after RCL implementation among respondents aged 21-30 years (+1.2%; aOR= 1.15 [95%CI = 1.04-1.27]), 31-40 years (+1.0; 1.15 [1.04-1.27]), and 41-50 years (+1.75; 1.63 [1.34-1.98]), but not in individuals aged <21 or 51+ years.
Implementation of recreational cannabis policies resulted in increased simultaneous use of cannabis and alcohol, supporting the complementarity hypothesis, but only among adults aged 21+. Efforts to minimize harms related to simultaneous cannabis/alcohol use are critical, especially in states with RCLs. Future studies should investigate cultural norms, perceived harm, and motives related to simultaneous use.
同时使用大麻和酒精,即在短时间内同时使用两种物质,其效果会重叠,比单独使用一种物质的潜在负面影响风险更大,并且在年轻人群中更为常见。娱乐用大麻法规(RCLs)与同时使用大麻和酒精流行率变化之间的关系尚未得到验证。
本研究旨在调查 2008 年至 2019 年期间同时使用大麻和酒精的趋势,并研究美国(U.S.)实施 RCLs(即存在活跃的合法药房或合法家庭种植)与同时使用大麻和酒精之间的关联。
重复的横截面样本来自 2008 年至 2019 年美国国家毒品使用和健康调查(NSDUH)。
年龄在 12 岁及以上的应答者(51%为女性)。
在控制医用大麻法实施的情况下,比较 RCL 实施前后不同年龄组(12-20 岁、21-30 岁、31-40 岁、41-50 岁、51 岁及以上)同时使用大麻和酒精的变化,使用具有州随机截距和 RCL/年龄组交互作用的调整后的多级逻辑回归。
自我报告的同时使用大麻和酒精。
从 2008 年至 2019 年,12-20 岁人群的同时使用大麻和酒精的总体流行率下降,但 21 岁及以上成年人的流行率上升。RCL 实施后,21-30 岁(+1.2%;优势比[aOR]=1.15[95%置信区间(CI)=1.04-1.27])、31-40 岁(+1.0%;1.15[1.04-1.27])和 41-50 岁(+1.75%;1.63[1.34-1.98])应答者的基于模型的同时使用大麻和酒精的流行率增加,但 21 岁以下或 51 岁及以上的应答者则不然。
娱乐用大麻政策的实施导致大麻和酒精同时使用增加,支持互补假说,但仅在 21 岁及以上的成年人中如此。努力减少与同时使用大麻和酒精相关的危害至关重要,尤其是在有 RCL 的州。未来的研究应调查与同时使用相关的文化规范、感知危害和动机。